Literature DB >> 7686115

Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France.

S Ranger1, P Martin, M C Roussanne, F Denis.   

Abstract

In this study of hepatitis C virus (HCV) infection prevalence in France, the prevalence of antibodies to HCV (as tested by second generation ELISA, with RIBA-2 confirmation in ELISA 2 positive samples) was found to be low (0.3%) in the healthy general population. HCV infection prevalence increased in the general population in association with African or Asian origin and risk factors such as bisexuality, previous history of transfusion, and intravenous drug abuse. The prevalence of anti-HCV infection was also higher in specific patient groups infected with HIV or a history of transfusion or haemodialysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686115      PMCID: PMC1374005          DOI: 10.1136/gut.34.2_suppl.s50

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  3 in total

Review 1.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

Authors:  Q L Choo; A J Weiner; L R Overby; G Kuo; M Houghton; D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

2.  [Prevalence of antibodies to the hepatitis C virus in pregnant foreign residents in France].

Authors:  L Aussel; F Denis; S Ranger; P Martin; M Caillaud; J Alain; J Baudet; J L Tabaste
Journal:  Pathol Biol (Paris)       Date:  1991-12

3.  [Seroprevalence of hepatitis C in human immunodeficiency virus infected patients].

Authors:  S Ranger; L Aussel; P Weinbreck; V Loustaud; A M Rogues; M Mounier; C Delpeyroux; F Denis
Journal:  Pathol Biol (Paris)       Date:  1991-02
  3 in total
  5 in total

1.  Prevalence of serum antibodies to hepatitis C virus is not increased in patients with multiple sclerosis.

Authors:  O Heinzlef; E Roullet; C Johanet; E Tournier-Lasserve; O Chazouilleres
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

Review 2.  Platelet dysfunction: a new dimension in inflammatory bowel disease.

Authors:  C E Collins; D S Rampton
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

3.  Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand.

Authors:  P Sawanpanyalert; S Boonmar; T Maeda; Y Matsuura; T Miyamura
Journal:  J Epidemiol Community Health       Date:  1996-04       Impact factor: 3.710

4.  Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C.

Authors:  A Tran; G Yang; A Doglio; M Ticchioni; C Laffont; J Durant; J L Bernard; J Gugenheim; M C Saint-Paul; A Bernard; P Rampal; S Benzaken
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

5.  Helicobacter pylori culture supernatant interferes with epidermal growth factor-activated signal transduction in human gastric KATO III cells.

Authors:  R Pai; F A Wyle; T L Cover; R M Itani; M J Domek; A S Tarnawski
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.